Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Advantest | 3.21% | $4.97M | ¥19.31T | 220.01% | 75 Outperform | |
| HSBC Holdings | 2.97% | $4.59M | £224.21B | 49.04% | 80 Outperform | |
| Novartis AG | 2.17% | $3.36M | CHF234.28B | 25.89% | 80 Outperform | |
| ASML Holding NV | 1.96% | $3.03M | €461.36B | 67.14% | 76 Outperform | |
| Shell (UK) | 1.93% | $2.98M | £164.82B | 9.90% | 73 Outperform | |
| Barclays | 1.84% | $2.85M | £65.87B | 62.83% | 78 Outperform | |
| Banco Bilbao Vizcaya Argentaria | 1.70% | $2.62M | €115.03B | 64.17% | 76 Outperform | |
| BNP Paribas | 1.66% | $2.56M | €102.40B | 32.12% | 77 Outperform | |
| ABB Ltd | 1.63% | $2.52M | kr1.47T | 35.54% | 78 Outperform | |
| UBS Group AG | 1.63% | $2.52M | $132.19B | 26.22% | 73 Outperform |